Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma

Laryngoscope

Volumn 123, Issue 11, 2013, Pages 2681-2689

  Day, Kristine E ^a   Beck, Lauren N ^a   Deep, Nicholas L ^a   Kovar, Joy ^c   Zinn, Kurt R ^b   Rosenthal, Eben L ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c LI COR BIOSCIENCES   (United States)

Author keywords

animal model; antibody; Cutaneous; fluorescence; head and neck; melanoma; optical imaging; surgery

Indexed keywords

BEVACIZUMAB; IMMUNOGLOBULIN G; PANITUMUMAB; TOCILIZUMAB;

ANIMAL EXPERIMENT; ANIMAL MODEL; BINDING AFFINITY; CONFERENCE PAPER; CONTROLLED STUDY; FLUORESCENCE IMAGING; FLUORESCENT ANTIBODY TECHNIQUE; MELANOMA; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; TISSUE CULTURE; TUMOR XENOGRAFT;

ANIMAL MODEL; ANTIBODY; CUTANEOUS; FLUORESCENCE; HEAD AND NECK; MELANOMA; OPTICAL IMAGING; SURGERY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; BENZENESULFONATES; CELL LINE, TUMOR; FEMALE; FLUORESCENT DYES; INDOLES; INTRAOPERATIVE CARE; MELANOMA; MICE; SKIN NEOPLASMS;

EID: 84886822277     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24102     Document Type: Conference Paper

References (34)

1. Tannous Z, Al-Arashi M, Shah S, Yaroslavsky AN,. Delineating melanoma using multimodal polarized light imaging. Lasers Surg Med 2009; 41: 10-16.
2. Urist MM, Balch CM, Soong SJ, et al. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment. Ann Surg 1984; 200: 769-775.
3. O'Brien CJ, Coates AS, Petersen-Schaefer K, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991; 162: 310-314.
4. Chang KH, Dufresne R, Jr, Cruz A, Rogers GS,. The operative management of melanoma: where does Mohs surgery fit in? Dermatol Surg 2011; 37: 1069-1079.
5. Trotter MJ,. Melanoma margin assessment. Clin Lab Med 2011; 31: 289-300.
6. El Tal AK, Abrou AE, Stiff MA, Mehregan DA,. Immunostaining in Mohs micrographic surgery: a review. Dermatol Surg 2010; 36: 275-290.
7. Keereweer S, Kerrebijn JD, Mol IM, et al. Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis. Head Neck 2012; 34: 1002-1008.
8. Mimeault M, Batra SK,. Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas. World J Clin Oncol 2012; 3: 32-42.
9. Gu F, Qureshi AA, Niu T, et al. Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma. Melanoma Res 2008; 18: 330-335.
10. Gleysteen JP, Duncan RD, Magnuson JS, Skipper JB, Zinn K, Rosenthal EL,. Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment. Cancer Biol Ther 2007; 6: 1181-1185.
11. Withrow KP, Newman JR, Skipper JB, et al. Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts. Technol Cancer Res Treat 2008; 7: 61-66.
12. Lee SB, Hassan M, Fisher R, et al. Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res 2008; 14: 3840-3849.
13. Heath CH, Deep NL, Sweeny L, Zinn KR, Rosenthal EL,. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol 2012; 19: 3879-3887.
14. Biosciences L-C., 2007IRDye(R) 800 CW protein labeling kit-high MW. Lincoln, NE: Li-Cor Biosciences; 2007.
15. Kulbersh BD, Duncan RD, Magnuson JS, Skipper JB, Zinn K, Rosenthal EL,. Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Arch Otolaryngol Head Neck Surg 2007; 133: 511-515.
16. Rosenthal EL, Kulbersh BD, Duncan RD, et al. In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence. Laryngoscope 2006; 116: 1636-1641.
17. Schneider CA, Rasband WS, Eliceiri KW,. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9: 671-675.
18. Bobek V, Kolostova K, Pinterova D, et al. A clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma. Anticancer Res 2010; 30: 4799-4803.
19. Reuthebuch O, Haussler A, Genoni M, et al. Novadaq SPY: intraoperative quality assessment in off-pump coronary artery bypass grafting. Chest 2004; 125: 418-424.
20. Mieog JS, Hutteman M, van der Vorst JR, et al. Image-guided tumor resection using real-time near-infrared fluorescence in a syngeneic rat model of primary breast cancer. Breast Cancer Res Treat 2011; 128: 679-689.
21. Keereweer S, Kerrebijn JD, van Driel PB, et al. Optical image-guided surgery-where do we stand? Mol Imaging Biol 2011; 13: 199-207.
22. Uhara H, Yamazaki N, Takata M, et al. Applicability of radiocolloids, blue dyes and fluorescent indocyanine green to sentinel node biopsy in melanoma. J Dermatol 2012; 39: 336-338.
23. Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F,. Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer. J Surg Oncol 2012; 106: 41-45.
24. Brouwer OR, Klop WM, Buckle T, et al. Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer. Ann Surg Oncol 2012; 19: 1988-1994.
25. Bradbury MS, Phillips E, Montero PH, et al. Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions. Integr Biol (Camb) 2013; 5: 74-86.
26. van der Vorst JR, Schaafsma BE, Verbeek FP, et al. Dose optimization for near-infrared fluorescence sentinel lymph node mapping in melanoma patients. Br J Dermatol 2013; 168: 93-98.
27. Chen Y, Pullambhatla M, Banerjee SR, et al. Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen. Bioconjug Chem 2012; 23: 2377-2385.
28. Nakajima T, Mitsunaga M, Bander NH, Heston WD, Choyke PL, Kobayashi H,. Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate. Bioconjug Chem 2011; 22: 1700-1705.
29. Hadjipanayis CG, Jiang H, Roberts DW, Yang L,. Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening. Semin Oncol 2011; 38: 109-118.
30. Adams KE, Ke S, Kwon S, et al. Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt 2007; 12: 024017.
31. Gurtner GC, Jones GE, Neligan PC, et al. Intraoperative laser angiography using the SPY system: review of the literature and recommendations for use. Ann Surg Innov Res 2013; 7: 1.
32. van der Vorst JR, Schaafsma BE, Verbeek FP, et al. Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients. Oral Oncol 2013; 49: 15-19.
33. Kishimoto T,. The biology of interleukin-6. Blood 1989; 74: 1-10.
34. Marshall MV, Draney D, Sevick-Muraca EM, Olive DM,. Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats. Mol Imaging Biol 2010; 12: 583-594.